Literature DB >> 9833984

BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.

E C de Lange1, G de Bock, A H Schinkel, A G de Boer, D D Breimer.   

Abstract

PURPOSE: The effect of P-glycoprotein (Pgp) on brain distribution using mdr1a (-/-) mice was investigated.
METHODS: Fluorescein (Flu) and FD-4 were used to check whether blood-brain barrier (BBB) integrity was maintained in mdr1a (-/-) mice. The Pgp substrate rhodamine-123 (R123) was infused and total brain, blood and brain microdialysate concentrations in mdr1a (-/-) mice and wild-type mice were compared.
RESULTS: Maintenance of BBB integrity was indicated by equal total brain/blood ratios of Flu and FD-4 in both mice types. R123 concentrations in brain after i.v. infusion were about 4-fold higher in mdr1a (-/-) than in wild-type mice (P < 0.05), without changes in blood levels. After microdialysis experiments the same results were found, excluding artifacts in the interpretation of Pgp functionality by the use of this technique. However the 4-fold ratio in brain was not reflected in corresponding microdialysates. No local differences of R123 in the brain were found. By the no-net-flux method in vivo recovery appeared to 4.6-fold lower in mdrla (-/-) mice compared with wild-type mice.
CONCLUSIONS: Pgp plays an important role in R123 distribution into the brain. Using intracerebral microdialysis, changes in in vivo recovery by the absence or inhibition of Pgp (or active efflux in general) need to be considered carefully.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833984     DOI: 10.1023/a:1011988024295

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  36 in total

1.  Exploring multidrug resistance using rhodamine 123.

Authors:  D Kessel
Journal:  Cancer Commun       Date:  1989

2.  Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeability.

Authors:  E C de Lange; M Danhof; C Zurcher; A G de Boer; D D Breimer
Journal:  Brain Res       Date:  1995-12-08       Impact factor: 3.252

3.  Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine.

Authors:  B Moghaddam; B S Bunney
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

4.  Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell.

Authors:  A Yoshimura; Y Kuwazuru; T Sumizawa; S Ikeda; M Ichikawa; T Usagawa; S Akiyama
Journal:  Biochim Biophys Acta       Date:  1989-09-15

5.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

Review 6.  Multidrug resistance mediated by P-glycoproteins.

Authors:  A H Schinkel; P Borst
Journal:  Semin Cancer Biol       Date:  1991-08       Impact factor: 15.707

7.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain.

Authors:  E C de Lange; J D de Vries; C Zurcher; M Danhof; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

9.  Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

Authors:  N Kartner; J R Riordan; V Ling
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

10.  The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics.

Authors:  E C de Lange; M B Hesselink; M Danhof; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

View more
  19 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.

Authors:  Matthew R Durk; Jianghong Fan; Huadong Sun; Yingbo Yang; Henrianna Pang; K Sandy Pang; Inés A M de Lannoy
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.

Authors:  R Xie; M R Bouw; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  [¹¹C]Rhodamine-123: synthesis and biodistribution in rodents.

Authors:  Xiaofeng Bao; Shuiyu Lu; Jeih-San Liow; Cheryl L Morse; Kacey B Anderson; Sami S Zoghbi; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2012-08-14       Impact factor: 2.408

6.  Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

Authors:  P J Gaillard; I C van der Sandt; L H Voorwinden; D Vu; J L Nielsen; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

7.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

Authors:  J Wijnholds; E C deLange; G L Scheffer; D J van den Berg; C A Mol; M van der Valk; A H Schinkel; R J Scheper; D D Breimer; P Borst
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 8.  Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.

Authors:  Thomas Gerloff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-04       Impact factor: 3.000

9.  ATP-dependent transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) and its xenobiotic taurine conjugate (Z-335-Tau) by rat bile canalicular membrane vesicles.

Authors:  Yoshihiro Kawabata; Emiko Kamada; Shigeru Furuta; Mineo Takei; Tadashi Kurimoto; Kazuho Okudaira; Ryuichiro Nishigaki
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 10.  Pharmacokinetics of non-intravenous formulations of fentanyl.

Authors:  Jörn Lötsch; Carmen Walter; Michael J Parnham; Bruno G Oertel; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.